PharmEco Group of Companies

Search

RU | EN

BioJet – EN
  • About
    • General information
    • Administration
    • Pharmacovigilance
    • Business ethics
  • Production
  • Our products
  • News
  • Contacts

Russian Ministry of Health: 480 Drugs Registered Since the Beginning of the Year

According to Russian Minister of Health Mikhail Murashko, approximately 480 drugs have been registered in the country since the start of 2024, with over 70% produced by domestic manufacturers. During the same period, Roszdravnadzor issued 1,800 registration certificates for medical devices, half of which are also of Russian origin. Murashko shared this information in his welcoming address to participants of the international forum “World Quality Day 2024.”

He noted that measures are being taken to develop domestic production of pharmaceutical substances and finished dosage forms. To ensure the quality control of medical products, Russia operates 13 federal laboratory complexes equipped with modern technology, which conduct quality checks on medicines available in the market. According to the minister, the existing system for monitoring the quality of medical products ensures the safety of the population.

Earlier in October, Murashko emphasized that import substitution and the adoption of domestic innovations are key strategic directions for the development of Russian healthcare. “Our goal is not only to maintain the production of vital medicines but also to develop new, groundbreaking treatment methods,” he said.

Source: GxP-news, November 13, 2024.

Current news

  • March 31, 2025

    Russian spending on antidepressants reached nearly 3 billion rubles since the beginning of the year

    Pharmacy chains earned 2.8 billion rubles from antidepressant sales in January-February 2025. A total of…

  • March 31, 2025

    The State Duma rejected the bill on accelerated market entry for generics

    On March 20, deputies of the State Duma rejected in the first reading a bill…

  • March 31, 2025

    Russia to increase production of infliximab-based medicines

    The company “Pharmapark” plans to steadily increase its production volumes. Specifically, over 30,000 packages of…

  • March 31, 2025

    A unified database for veterinary drugs will be launched in EAEU countries

    The Collegium of the Eurasian Economic Commission (EEC) has approved the creation of a unified…

  • March 31, 2025

    MSD will pay up to $2 billion for Chinese heart medication

    One of the world’s largest pharmaceutical companies, MSD, will pay up to $2 billion for…

LLC “BioJet”. all rights reserved

  • Legal information